Trial Profile
Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2021
Price :
$35
*
At a glance
- Drugs Tamibarotene (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- 25 Feb 2021 Status changed from recruiting to discontinued.
- 27 Oct 2010 New trial record